Generic and Personalized RNAi-Based Therapeutics for a Dominant-Negative Epidermal Fragility Disorder
- 1 June 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 132 (6), 1627-1635
- https://doi.org/10.1038/jid.2012.28
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Development of Allele-Specific Therapeutic siRNA for Keratin 5 Mutations in Epidermolysis Bullosa SimplexJournal of Investigative Dermatology, 2011
- Current prospects for RNA interference-based therapiesNature Reviews Genetics, 2011
- The Many Faces of RNAiDevelopmental Cell, 2011
- Increased interstitial pressure improves nucleic acid delivery to skin enabling a comparative analysis of constitutive promotersGene Therapy, 2010
- Broken bricks and cracked mortar – epidermal diseases resulting from genetic abnormalitiesDrug Discovery Today: Disease Mechanisms, 2008
- Single-Nucleotide-Specific siRNA Targeting in a Dominant-Negative Skin ModelJournal of Investigative Dermatology, 2008
- Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skinBritish Journal of Dermatology, 2006
- Great promises yet to be fulfilled: Defining keratin intermediate filament function in vivoEuropean Journal of Cell Biology, 2004
- Mutations in Keratin K9 in Kindreds with Epidermolytic Palmoplantar Keratoderma and Epidemiology in Northern IrelandJournal of Investigative Dermatology, 1998
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998